Cardiovascular risk classification requires dependable interpretation of interconnected clinical, metabolic, and lifestyle indicators within preventive healthcare analytics. Conventional learning approaches often face difficulty in preserving nonlinear dependencies across heterogeneous cardiovascular attributes. The proposed Variational Quantum Classifier with Hybrid Quantum-Classical Learning (VQC-HQCL) framework addresses such complexity through a structured quantum-assisted classification pathway. Clinical cardiovascular records undergo harmonisation and stratified partitioning to maintain stable, balanced learning conditions. Quantum feature encoding transforms prepared attributes into circuit-compatible states, enabling interaction-aware representation within a variational quantum architecture. The Variational Quantum Classifier functions as the predictive learning core, capturing discriminative cardiovascular patterns through parameterised circuit operations. Hybrid Quantum-Classical Learning supports iterative refinement by combining quantum state processing with classical parameter optimisation. Final classification assigns cardiovascular risk status for screening-oriented decision support in structured clinical practice. The framework contributes a medically grounded, computationally feasible approach for nonlinear cardiovascular relationship modelling and intelligent risk assessment under current quantum learning constraints.
Cardiovascular risk classification requires dependable interpretation of interconnected clinical, metabolic, and lifestyle indicators within preventive healthcare analytics. Conventional learning approaches often face difficulty in preserving nonlinear dependencies across heterogeneous cardiovascular attributes. The proposed Variational Quantum Classifier with Hybrid Quantum-Classical Learning (VQC-HQCL) framework addresses such complexity through a structured quantum-assisted classification pathway. Clinical cardiovascular records undergo harmonisation and stratified partitioning to maintain stable, balanced learning conditions. Quantum feature encoding transforms prepared attributes into circuit-compatible states, enabling interaction-aware representation within a variational quantum architecture. The Variational Quantum Classifier functions as the predictive learning core, capturing discriminative cardiovascular patterns through parameterised circuit operations. Hybrid Quantum-Classical Learning supports iterative refinement by combining quantum state processing with classical parameter optimisation. Final classification assigns cardiovascular risk status for screening-oriented decision support in structured clinical practice. The framework contributes a medically grounded, computationally feasible approach for nonlinear cardiovascular relationship modelling and intelligent risk assessment under current quantum learning constraints.
Cardiovascular diseases remain a major challenge in healthcare, requiring accurate and early risk identification to support preventive intervention. Reliable prediction demands models capable of capturing complex relationships among physiological and lifestyle attributes. Conventional machine learning approaches face limitations in representing nonlinear dependencies within clinical data. To address this challenge, a Quantum Kernel Support Vector Machine (QK-SVM) framework is proposed for cardiovascular risk classification. The approach transforms clinical features into quantum states through parametric encoding, enabling interaction aware representation using entanglement mechanisms. A Quantum Feature Interaction Index is introduced to quantify relational dependencies among encoded attributes, strengthening similarity evaluation. The resulting quantum kernel matrix reflects enriched feature interactions and supports margin-optimized classification within a high-dimensional space. The framework maintains alignment with clinical data characteristics while enhancing representation fidelity and decision boundary formation. This structured integration of quantum feature mapping and support vector learning establishes an effective methodology for cardiovascular risk screening in intelligent healthcare systems.
Cardiovascular disease remains one of the leading causes of death worldwide, making early and accurate risk prediction essential. Conventional machine learning models often struggle to handle complex medical data, resulting in limited accuracy and reduced interpretability. To address these challenges, this study presents a hybrid prediction framework that combines Quantum Machine Learning (QML) with ensemble learning techniques. Classical models such as Support Vector Classifier (SVC) and Artificial Neural Network (ANN) are used as baseline approaches. In addition, quantum models including QSVC, Variational Quantum Classifier (VQC), and Quantum Neural Network (QNN) are employed to capture complex non-linear patterns present in clinical data. To further enhance performance, a Bagging-QSVC ensemble model is proposed, improving robustness and overall classification accuracy. Interpretability is incorporated using SHAP, allowing the model’s predictions to be more transparent and easier to understand in a clinical context. Experimental results indicate that the proposed quantum ensemble achieves an accuracy of around 90%, outperforming both classical models and individual quantum models. Furthermore, a real-time user interface is developed, enabling clinicians to input patient data and receive immediate risk predictions. Overall, the system provides a reliable and interpretable solution suitable for practical clinical decision support.
Early and accurate recognition of cardiovascular disease (CVD) using medical imaging is essential for timely clinical intervention and management. The objective of this study was to continue developing a hybrid quantum-classical deep learning system for the early detection and automatic triage of cardiovascular diseases using cardiac imaging information. The proposed method consists of a combination of efficient feature extraction via a lightweight classical convolutional neural network and a quantum-illness feature transformation and decision-refinement process implemented as a variational quantum circuit. A clinically informed triage module was added to rate patients into three risk categories (low-, moderate-, and high-risk). Experimental evaluation on a public cardiac magnetic resonance imaging (MRI) dataset revealed that the proposed framework achieved 94.5% classification accuracy and an area under the curve (AUC) of 0.96, with sensitivity exceeding that of state-of-the-art classical deep learning models. The results show that quantum-enhanced feature representations provide better class separability, robustness to Imaging noise, and improved learning efficiency. The results suggest that one way to overcome the limitations of conventional deep models is the hybrid quantum-classical learning approach, which is also compatible with near-term quantum hardware. This work raises the question of whether quantum-assisted artificial intelligence can enable scalable, real-time cardiovascular decision support systems and promote next-generation intelligent healthcare systems.
Heart disease is one of the major global causes of death, requiring early and precise detection for efficient treatment.With advancements in quantum computing, Variational Quantum Circuits (VQCs) have gained recognition as a valuable technique for improving learning models in medical diagnosis.This study further explores the application of VQC-based models for heart disease prediction, leveraging quantum computing to enhance classification accuracy.A hybrid quantum-classical model has been developed, which combines classical preprocessing for feature extraction from patient datasets with a VQC-based classifier for medical predictions.The quantum circuit using variational parameters is optimized to reduce the loss function and facilitate effective learning from complex medical data.This proposed approach is tested on benchmark heart disease datasets and evaluated against classical Machine Learning (ML) models, including Support Vector Machines (SVMs), Random Forests, and Neural Networks.The experimental results show that VQC-based models achieve high accuracy and outperform classical models, notably on high-dimensional, non-linearly separable data.The quantum advantage of VQCs lies in their ability to encode and process data in a huge Hilbert space.However, challenges such as noise in near-term quantum devices and scalability issues remain key.This research underscores the efficacy of VQCbased quantum machine learning in medical diagnosis, paving the way for future studies on quantum-enhanced healthcare solutions.Further advancements in quantum hardware and hybrid learning techniques could allow quantum-assisted heart disease prediction to become an effective clinical tool.
Cardiovascular diseases remain a leading global health challenge, driving the need for advanced, accurate diagnostic tools. While classical machine learning (ML) models like XGBoost have achieved significant success in medical diagnosis, they often face challenges related to accuracy plateaus and model explainability in complex, high-dimensional data spaces. Quantum machine learning (QML) emerges as a promising paradigm to potentially overcome these limitations by leveraging quantum computational advantages. This study aims to develop and evaluate a hybrid quantum-classical pipeline for the early detection of heart disease. We integrate robust data preprocessing—including missing value imputation, feature engineering, SMOTE for class balancing, and PCA for dimensionality reduction—with two classification approaches: a classical XGBoost model and a quantum Variational Quantum Classifier (VQC). Our results demonstrate that the XGBoost model achieves strong performance with an accuracy of 88.52% and an F1-score of 0.8852 on an imbalanced test set. While the VQC model did not surpass the classical baseline in the current noisy simulation environment, it shows theoretical promise. This work highlights the practical challenges of current QML and outlines a clear pathway for future research towards achieving a quantum advantage in clinical decision support systems.
Abstract Heart disease remains to be a primary cause of death globally, requiring precise and timely predictive methodologies. Traditional machine learning methods that depend exclusively on classical clinical variables frequently have restricted predictive accuracy and do not adequately use the intricate nonlinear interactions present in patient data. This work examines the effectiveness of hybrid quantum-classical models for predicting heart disease by combining classical clinical data with quantum-derived representations via Variational Quantum Classifier (VQC), Estimator, and Sampler models. Twelve hybrid configurations, integrating three quantum feature maps (Z, ZZ, Pauli) with four ansatz architectures (RealAmplitudes, TwoLocal, EfficientSU2, PauliTwoDesign), were assessed inside the PennyLane and Qiskit frameworks. The results indicate that the VQC model in PennyLane reached optimal performance with Z–TwoLocal and ZZ–PauliTwoDesign configurations, achieving accuracy and F1-scores of up to 0.95. The Estimator model consistently produced reliable predictions, with Pauli–EfficientSU2 and Z–TwoLocal attaining accuracies of up to 0.91 and F1-scores of 0.92 across several frameworks. The Sampler model demonstrated 1reasonable performance, with the Pauli–EfficientSU2 configuration achieving an accuracy of 0.65 and an F1-score of 0.73, underscoring the supplementary role of stochastic quantum sampling. The analysis of feature significance indicated that the quantum-derived feature provided the most robust predictive signal, exceeding classical variables like Age, Blood Pressure, and Cholesterol. These findings demonstrate that meticulous alignment of feature maps and ansatz circuits is essential for optimizing model expressivity, convergence, and predictive effectiveness. In summary, hybrid quantum-classical models, especially the Estimator and VQC architectures, significantly improve heart disease prediction, providing a feasible method for precision clinical decision support and potential incorporation into privacy-preserving, multi-institutional healthcare systems.